AAV Craniotomy

By Santiago Unda, MD, Roberta Marongiu, PhD, Mihaela Stavarache and Michael Kaplitt, MD, PhD
View Published Protocol

Output Details

Description
This protocol is for injection of AAV into a mouse brain using a stereotactic frame and Hamilton syringe.
Identifier (DOI)
10.17504/protocols.io.5jyl829q7l2w/v1
Tags
  • AAV (Adenoassociated Virus)
  • Animal
  • In Vivo
  • Mouse
  • Stereotactic
  • Surgical
Team
Team Kaplitt
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits

Study shows increasing PGK1 gene expression enhances neuronal ATP production, protecting against synaptic dysfunction in Parkinson's disease. Boosting bioenergetics with PGK1 may be a promising therapeutic approach for PD.

View Article

AAV Production Protocol-Arber Lab

AAV Production methods used in Falasconi & Kanodia et al 2025 and is the general protocol for Arber Lab.

View Protocol

pAAVDJ-CAG-FlpX-mKate2.0-N2cG

The pAAV-CAG-fDIO-mKate2.0-N2cG vector was used as a helper virus in conjunction with a rabies virus to label presynaptic inputs to various regions in the brain with focus on SNr neurons.

View Lab Material
View More Outputs